Jeff Hall

The Revolution Vibe computed tomography system reportedly facilitates quality low-dose imaging for cardiac exams in patients with arrhythmias, heavily calcified coronaries and stents.

In a 10-study meta-analysis examining the use of whole-body MRI for asymptomatic individuals, researchers noted a pooled cancer detection rate of 1.57 percent.

From emerging research on disparities in breast cancer screening to the promising combination of contrast-enhanced mammography with DBT and a three-part podcast on abbreviated breast MRI, here is a look back at the most well-reviewed breast imaging content of the summer.

The AI-powered cardiovascular ultrasound device reportedly offers enhanced spatial and contrast resolution as well as bolstered 4D imaging that enables improved evaluation of cardiac function for a wide range of patients.

Featuring advanced detector technology, the Pharos PET scanner reportedly enhances detection of subtle anomalies across brain, breast and extremity imaging.

Combining advances in imaging quality with access to 26 FDA-cleared applications for automated and accelerated tasks, the Transcend Plus software will be featured at the upcoming European Society of Cardiology (ESC) and American Society of Echocardiography (ASE) conferences.

The MyLab A50 and MyLab A70 ultrasound platforms reportedly enable a variety of detailed and multiparametric evaluations, including assessments for liver elastography and strain analysis echocardiography.

Use of the AI-powered Salix Coronary Plaque module, which offers detection of high-risk plaque within 10 minutes based off of CCTA scans, will reportedly qualify for $950 in Category 1 CPT reimbursement in 2026.

In a new podcast, Krishna Nallamshetty, M.D., shares his thoughts on key contributing factors to burnout in radiology, and discusses practical approaches and emerging technology that may help mitigate the issue.

A model combining deep learning features and clinical variables demonstrated a 30 percent higher AUC than a clinical model for detecting DCIS and invasive ductal carcinoma from suspicious microcalcifications on mammography, according to a new study.

Over 26 percent of AI-detected future breast cancers and interval breast cancers missed by radiologists were invasive cancers, according to newly published research involving over 42,000 women who had 2D screening mammography.

Nine months after initiation of androgen deprivation therapy (ADT), prostate cancer patients with higher myocardial extracellular volume (ECV) — derived from chest contrast-enhanced CT — had over a fourfold higher risk for major adverse cardiovascular events (MACEs), according to new research.

In a recent interview, Ioannis Sechopoulos, Ph.D, and Sarah D. Verboom, MSc discussed their new research examining the role of certainty in AI mammography screening assessment and the potential impact on workload reduction for radiologists.

In a new review of MRI-based scoring systems for T-staging of prostate cancer, researchers discuss key literature findings and principles in evaluating the extent of prostate cancer (PCa) lesions, and whether a focus on specificity could enhance the staging of PCa.

In the second part of a recent interview, Tammie Benzinger, M.D., Ph.D., discusses recently presented research from the Alzheimer’s Association International Conference (AAIC) that showed the ability of portable low-field MRI to detect mild and moderate amyloid-related imaging abnormalities (ARIAs).

Catch up on the latest news, research and insights in radiology with our Weekly Scan.

Reportedly the only point-of-care ultrasound system that can estimate liver stiffness and attenuation that correlate to MRI-PDFF, Velacur One also may facilitate higher reimbursement than non-imaging elastography.

In the second part of a recent interview, Chris Mattern. M.D., discussed the increasing burden of non-clinical tasks upon radiologist workloads and the potential of the emerging enterprise imaging platform MosaicOS to address efficiency and restore the focus on clinical care.

Incorporating technology from Siemens Healthineers’ Magnetom Skyra Fit system, the Invision 3T Recharge Operating Suite offers AI-powrred protocols and automated image reconstruction capabilities.

Could the NeedleVue LC1 Ultrasound System reinvent real-time ultrasound-assisted needle guidance for interventional procedures?

In the second of a two-part podcast episode, Jeremie Calais, M.D., and Robert Flavell, M.D., discuss current and emerging alpha-emitting therapies, possible roles for artificial intelligence (AI), and what the future may hold for theranostic applications in patients with prostate cancer.

Emphasizing advanced orchestration of imaging workflows, the Rhapsody Image Director software reportedly facilitates streamlined efficiency and infrastructure that accommodates multimodal AI tools.

Patient with biochemical recurrence of prostate cancer who had PSMA PET/CT prior to salvage radiotherapy had better survival rates at one, two and five years, according to newly published research.

Researchers noted a 78 percent malignancy rate when associated architectural distortion was present on digital breast tomosynthesis (DBT) with highly suspicious masses or microcalcifications.

The iPETcertum software reportedly provides automated segmentation and enhanced visualization of regions of interest on PET scans with a single click.

In a recent interview, Tammie Benzinger, M.D., Ph.D., discussed the utility of portable low-field MRI to help identify patients in remote settings who may be viable candidates for subsequent MRI workup and consideration for new anti-amyloid therapies in treating Alzheimer’s disease.

In comparison to computed tomography and bone scintigraphy, FDG PET/CT detected more oligometastatic and polymetastatic disease in patients with locally advanced breast cancer, according to a new study.

A deep learning multimodal model that incorporates MRI features offered nearly double the sensitivity for predicting post-prostatectomy biochemical recurrence of prostate cancer in comparison to the traditional CAPRA-S scoring system.

In the first of a two-part podcast episode, Jeremie Calais, M.D., and Robert Flavell, M.D., discuss recent advances with PSMA-targeted radiotracers in the treatment of metastatic castration-resistant prostate cancer (mCRPC), and the role of imaging criteria in monitoring patients treated with PSMA-targeted radionuclide therapy.

In addition to facilitating centralized scanning for a variety of imaging, the TechLive system may help ease the strain of technologist shortages and broaden access to advanced imaging exams.